CoChat

Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection

Open access
de Roda Husman, Ana-Maria, Koot, Maarten, Cornelissen, Marion, Keet, Ireneus P.M., Brouwer, Margreet, Broersen, Silvia M., Bakker, Margreet, Roos, Marijke T.L., Prins, Maria, de Wolf, Frank, Coutinho, Roel A., Miedema, Frank, Goudsmit, Jaap, Schuitemaker, Hanneke · 1997 · Annals of Internal Medicine
Cited by 267

The DOI matches its Crossref record.

Abstract

BACKGROUND: Heterozygosity for a 32-nucleotide deletion in the C-C chemokine receptor 5 gene (CCR5 delta 32) is associated with delayed disease progression in persons infected with HIV-1. OBJECTIVE: To compare the predictive value of CCR5 genotype with that of established markers in the clinical course of HIV-1 infection. DESIGN: Retrospective longitudinal study and nested case-control study. The latter included only long-term survivors, who were individually matched with progressors. SETTING: Amsterdam, the Netherlands. PARTICIPANTS: 364 homosexual men with HIV-1 infection. MEASUREMENTS: Polymerase chain reaction was used for CCR5 genotyping. Univariate and multivariate Cox proportional hazard analyses were done for disease progression with CCR5 genotype, CD4+ T-lymphocyte counts, T-lymphocyte function, HIV-1 biological phenotype (syncytium-inducing or non-syncytium-inducing HIV-1), and viral RNA load in serum as covariates. RESULTS: In the case-control study, 48% of long-term survivors were heterozygous for CCR5 delta 32 compared with 9% of progressors (odds ratio, 6.9 [95% CI, 1.9 to 24.8]). In the total study sample, CCR5 delta 32 heterozygotes had significantly delayed disease progression (P < 0.001; relative hazard, 0.4 [CI, 0.3 to 0.6]), a 1.5-fold slower decrease in CD4+ T-lymphocyte count (P = 0.01), and a 2.6-fold lower viral RNA load (P = 0.01) at approximately 2.3 years after seroconversion compared with CCR5 wild-type homozygotes. At the end of the study, both groups showed the same prevalence of syncytium-inducing HIV-1, but CCR5 delta 32 heterozygotes had a delayed conversion rate. The protective effect of CCR5 delta 32 heterozygosity was stronger in the presence of only non-syncytium-inducing HIV-1. The CCR5 genotype predicted disease progression independent of viral RNA load, CD4+ T-lymphocyte counts, T-lymphocyte function, and HIV-1 biological phenotype. CONCLUSIONS: The addition of CCR5 genotype to currently available laboratory markers may allow better estimation of the clinical course of HIV-1 infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-127-10-199711150-00004

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 267

Metadata

Authors
de Roda Husman, A.-M., Koot, M., Cornelissen, M., Keet, I. P. M., Brouwer, M., Broersen, S. M., Bakker, M., Roos, M. T. L., Prins, M., de Wolf, F., Coutinho, R. A., Miedema, F., Goudsmit, J., & Schuitemaker, H.
Venue
Annals of Internal Medicine
Published
1997-11-15
Volume
127
Issue
10
Pages
882-890
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W1551243371
Cited by
267
References
0
FWCI
6.71
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection. https://app.cochat.ai/papers/10.7326/0003-4819-127-10-199711150-00004
The paper
de Roda Husman, A.-M., Koot, M., Cornelissen, M., Keet, I. P. M., Brouwer, M., Broersen, S. M., Bakker, M., Roos, M. T. L., Prins, M., de Wolf, F., Coutinho, R. A., Miedema, F., Goudsmit, J., & Schuitemaker, H. (1997). Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-127-10-199711150-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.